These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 346213

  • 1. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
    Levine AS, Appelbaum FR, Graw RG, Magrath IT, Pizzo PA, Poplack DG, Ziegler JL.
    Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E, Wilbur JR.
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [Abstract] [Full Text] [Related]

  • 3. [Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)].
    Pontz BF, Gutjahr P.
    Dtsch Med Wochenschr; 1981 Feb 13; 106(7):200-7. PubMed ID: 6937343
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant treatment of osteogenic sarcoma with high-dose cyclophosphamide.
    Shepp M, Necheles TF, Banks HH, Oh WH, Zimbler S.
    Cancer Treat Rep; 1978 Feb 13; 62(2):295-6. PubMed ID: 346220
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy for osteosarcoma.
    Pratt CB, Rivera G, Shanks E, Kumar AP, Green AA, George S.
    Cancer Treat Rep; 1978 Feb 13; 62(2):251-7. PubMed ID: 346214
    [Abstract] [Full Text] [Related]

  • 6. High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
    Jaffe N, Frei E, Watts H, Traggis D.
    Cancer Treat Rep; 1978 Feb 13; 62(2):259-64. PubMed ID: 346215
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
    Prindull G, Poppe H, Jentsch E, Schauer A.
    Unfallheilkunde; 1981 Dec 13; 84(12):524-5. PubMed ID: 6948465
    [No Abstract] [Full Text] [Related]

  • 8. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
    Gilchrist GS, Ivins JC, Ritts RE, Pritchard DJ, Taylor WF, Edmonson JM.
    Cancer Treat Rep; 1978 Feb 13; 62(2):289-94. PubMed ID: 346219
    [Abstract] [Full Text] [Related]

  • 9. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R, Leber H, Ramach W, Arbes H, Wolf A.
    Wien Klin Wochenschr; 1977 Jul 15; 89(14):474-9. PubMed ID: 70889
    [Abstract] [Full Text] [Related]

  • 10. High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma.
    Pratt CB, Howarth C, Ransom JL, Bowles D, Green AA, Kumar AP, Rivera G, Evans WE.
    Cancer Treat Rep; 1980 Jan 15; 64(1):11-20. PubMed ID: 6966535
    [Abstract] [Full Text] [Related]

  • 11. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G, Tan C, Sanmaneechai A, Beattie EJ, Marcove R, Murphy ML.
    Cancer; 1975 Mar 15; 35(3 suppl):936-45. PubMed ID: 1078642
    [Abstract] [Full Text] [Related]

  • 12. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G, Huvos AG, Marcove R, Nirenberg A.
    Clin Orthop Relat Res; 1986 Jun 15; (207):164-73. PubMed ID: 2424660
    [Abstract] [Full Text] [Related]

  • 13. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K, Matsuoka H, Murakami T, Fujimoto T, Takayanagi F, Sawai K, Niwa J, Hara K.
    Gan To Kagaku Ryoho; 1986 May 15; 13(5):1837-45. PubMed ID: 3486634
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low-dose semicontinuous chemotherapy. EORTC Osteosarcoma Working Party Group.
    Recent Results Cancer Res; 1978 May 15; 68():28-32. PubMed ID: 288108
    [No Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD, Desser RK, DeMeester TR, Colman M, Evans R, Billings A, Griem M, Rubenstein L, Shapiro C, Golomb HM.
    Cancer Treat Rep; 1976 Sep 15; 60(9):1225-30. PubMed ID: 189920
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy in osteogenic sarcoma.
    Tichler TE, Am YB, Brenner HJ.
    Prog Clin Biol Res; 1982 Sep 15; 99():49-75. PubMed ID: 6983080
    [No Abstract] [Full Text] [Related]

  • 18. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ, Freeman AI, Douglass HO, Higby DS, Mindell ER, Sinks LF.
    Cancer Treat Rep; 1978 Feb 15; 62(2):239-45. PubMed ID: 346212
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H, Kosloff C, Nirenberg A, Mehta BM, Huvos AG, Rosen G.
    Natl Cancer Inst Monogr; 1981 Apr 15; (56):221-6. PubMed ID: 6975439
    [Abstract] [Full Text] [Related]

  • 20. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
    Jaffe N, Frei E, Traggis D, Cassady JR, Watts H, Filler RM.
    Cancer Treat Rep; 1977 Jul 15; 61(4):675-9. PubMed ID: 301780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.